Jazz Pharmaceuticals

Yahoo Finance • 2 months ago

Jazz Pharmaceuticals' Zepzelca/Tecentriq Combo Regimen Can Potentially Delay Disease Progression, Extend Survival In Aggressive Form Of Lung Cancer

Jazz Pharmaceuticals' Zepzelca/Tecentriq Combo Regimen Can Potentially Delay Disease Progression, Extend Survival In Aggressive Form Of Lung Cancer Jazz Pharmaceuticals plc (NASDAQ:JAZZ) revealed topline results from the Phase 3 clinical... Full story

Yahoo Finance • 3 months ago

Is Jazz Pharmaceuticals plc (NASDAQ:JAZZ) The Top Stock With Improving Technical Ratings According To Piper Sandler?

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where Jazz Pharmaceuticals plc (NASDAQ:JAZZ) ranks among the list of stocks with improving technical rating according to P... Full story

Yahoo Finance • 3 months ago

Jazz Pharmaceuticals plc (JAZZ): Why Are Hedge Funds Bullish On This Cheap Growth Stock Right Now?

We recently compiled a list of the 8 Best Cheap Growth Stocks To Invest In Now.In this article, we are going to take a look at where Jazz Pharmaceuticals plc (NASDAQ:JAZZ) stands against the other cheap growth stocks. What Should Your Por... Full story

Yahoo Finance • 3 months ago

Jazz Pharmaceuticals' (NASDAQ:JAZZ) earnings have declined over five years, contributing to shareholders 16% loss

The main aim of stock picking is to find the market-beating stocks. But every investor is virtually certain to have both over-performing and under-performing stocks. At this point some shareholders may be questioning their investment in Ja... Full story

Yahoo Finance • 4 months ago

Jazz Pharmaceuticals to Present New Data Demonstrating Improved Epilepsy Outcomes with Epidiolex®/Epidyolex® (cannabidiol) at the European Epilepsy Congress 2024

Data from eight abstracts to be presented, including results of the BECOME (BEhavior, COgnition and More with Epidyolex®) Caregiver Survey on the real-world outcomes of Epidyolex® (cannabidiol) treatment on patients with Lennox-Gastaut Syn... Full story

Yahoo Finance • 4 months ago

Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences

DUBLIN, Aug. 21, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the following investor conferences: Wells Fargo Healthcare Conference on Wednesday, September 4, 202... Full story

Yahoo Finance • 11 months ago

4 Eye-Catching Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip

There's never a dull moment when investing on Wall Street. Over the last four years, the major stock indexes have bounced between bear and bull markets on a couple of occasions, with the growth-fueled Nasdaq Composite(NASDAQINDEX: ^IXIC) e... Full story

Yahoo Finance • 11 months ago

2 Incredible Growth Stocks That Are Screaming Buys for 2024

The new year is here, and for many, it's a fresh opportunity to set financial goals and find fresh stocks to consider adding to a portfolio. The types of stocks you gravitate toward will broadly be informed by your personal risk tolerance... Full story

Yahoo Finance • 11 months ago

4 Remarkable Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip

It's truly incredible what a difference a year can make on Wall Street. In 2022, the growth-fueled Nasdaq Composite(NASDAQINDEX: ^IXIC) shed 33% of its value during a bear market. But in 2023, growth stocks came back with a vengeance and l... Full story

Yahoo Finance • last year

Jazz Pharmaceuticals' Post-Traumatic Stress Disorder Drug Disappoints In Mid-Stage Study

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced top-line results from the Phase 2 trial of JZP150, an investigational small molecule selective fatty acid amide hydrolase (FAAH) inhibitor, on efficacy and safety in adults with post-trauma... Full story

Yahoo Finance • last year

Jazz Pharmaceuticals' 2022 Corporate Sustainability and Social Impact Report: Using Natural Resources Responsibly

NORTHAMPTON, MA / ACCESSWIRE / November 29, 2023 / Jazz Pharmaceuticals Originally Published in Jazz Pharmaceuticals' 2022 Corporate Sustainability and Social Impact Report Management Approach We seek to operate our business in an envir... Full story

Yahoo Finance • last year

11 Best Cheap Stocks To Buy For Long Term

In this piece, we will take a look at the 11 best cheap stocks to buy now for the long term. If you want to skip our coverage of the latest stock market news and stock valuation, then take a look at 5 Best Cheap Stocks To Buy For Long Term... Full story

Yahoo Finance • last year

11 Best Cannabis Stocks To Buy Now

In this article, we discuss 11 best cannabis stocks to buy now. If you want to see more stocks in this selection, check out 5 Best Cannabis Stocks To Buy Now. Cannabis, a flowering plant genus, boasts a rich history of utilization, primar... Full story

Yahoo Finance • last year

Ligand Reports Third Quarter 2023 Financial Results

Raising 2023 Guidance Investor and Analyst Day to be held on Tuesday December 12th in New York City Conference call begins at 4:30 p.m. Eastern Time today SAN DIEGO, November 08, 2023--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporate... Full story

Yahoo Finance • last year

14 Best Cancer Stocks To Buy Now

In this article, we discuss 14 best cancer stocks to buy. If you want to skip our detailed discussion on the oncology industry, head directly to 5 Best Cancer Stocks To Buy Now. The global oncology landscape continues to evolve, with ongo... Full story

Yahoo Finance • last year

15 Stocks Billionaire Seth Klarman Likes the Most Now

In this article, we looked at what billionaire Seth Klarman thinks about the stock market outlook, his investing principles, and what he recommends to investors. We also reviewed year to date performance of 15 stocks billionaire Seth Klarm... Full story

Yahoo Finance • last year

12 High Growth Value Stocks to Buy According to Seth Klarman

In this article, we will take a look at the 12 high growth value stocks to buy according to Seth Klarman. To see more such companies, go directly to 5 High Growth Value Stocks to Buy According to Seth Klarman. Following clear signals from... Full story

Yahoo Finance • 2 years ago

Jazz Pharmaceuticals Sues FDA Over Approval Of Rival Product, Calls It 'Unlawful'

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has filed suit against the FDA for approving Avadel Pharmaceuticals Plc's (NASDAQ: AVDL) Lumryz (sodium oxybate extended-release) for cataplexy or excessive daytime sleepiness in adult patients with... Full story

Yahoo Finance • 2 years ago

Essential Pharma appoints Lee Morley as Non-Executive Director to the Board

Essential Pharma appoints Lee Morleyas Non-Executive Director to the Board Zug, Switzerland & Egham, UK – 21June2023 – Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access to... Full story

Yahoo Finance • 2 years ago

13 Best Future Stocks for the Long-Term

In this piece, we will take a look at the 13 best future stocks for the long-term. For more stocks, head on over to 5 Best Future Stocks for the Long-Term. Investing these days is a ride not for the faint hearted. Within a couple of years... Full story